An Investigation of Crk Prote in Kinases of Leishmania and the Assessment of Their Potential as Drug Targets
An Investigation of Crk Prote in Kinases of Leishmania and the Assessment of Their Potential as Drug Targets
No Thumbnail Available
Date
2015-11-15
Authors
Ibrahim, Muntaser E.
Ali, Nahla
Aradaib, Imadeldin E.
Journal Title
Journal ISSN
Volume Title
Publisher
UOFK
Abstract
Cyclin-dependent kinases (CDKs), exemplified by cdc2, are key regulators of
the eukaryotic cell cycle [1]. A number of cdc2-related kinase genes have been
isolated from trypanosomatids [2-6]. The present study was designed to identify
and analyze cdc2-related protein kinases (CRKs), investigate their regulation
mechanisms, and thus their role in regulating the cell cycle of the protozoa
Leishmania donovani, the causative agent for Kala-azar and Leishmania
mexicana; the causative agent for New world cutaneous leishmaniasis. To
achieve this aim, CRK3 protein kinase gene was isolated from a Sudanese strain
of L. donovani, designated LdCRK3. It encodes a protein of 311 amino acids
with 99.7 % identity with the L. mexicana CRK3 and 49.4% identity with human
Hscdc2. Southern blot analysis showed that LdCRK3 is single copy, consistent
with the genomic organization of all the so-far identified trypanosomatid protein
kinases. The sequence of L. donovani CRK3 has been deposited in GenBankTM
under the access number AJ426472.
Description
Keywords
Crk Prote,
Kinases,
Leishmania,
Potential,
Drug Targets